0.00
-0.62%
Close of 9 Nov 2026, in USD
Search any instrument
Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.
About Target Group
From its filings with the US Securities and Exchange Commission
Target Group is based in Hamilton and is incorporated in Delaware. Its shares trade on OTC under the ticker CBDY. The SEC classifies its business as medicinal chemicals & botanical products. In the fiscal year to 31 December 2025, it reported revenue of $3.9m and a net loss of $1.4m. At that date it held total assets of $6.2m and shareholders' equity of −$8.1m.
Target Group Inc. (“Target Group” or the “Company”) was incorporated in the State of Delaware on July 2, 2013, under its original name of River Run Acquisition Corporation. Effective May 13, 2014, the Company changed its name to Chess Supersite Corporation. On July 3, 2018, the Company filed an amendment in its Certificate of Incorporation to change its name to Target Group Inc.
Effective July 1, 2025, the Company’s common stock is quoted on the Pink Limited Market operated by OTC Markets Group Inc, under the symbol “CBDY”.
The Company is engaged in the cultivation, processing and distribution of curated cannabis products for the medical and adult-use recreational cannabis market in Canada and continues to evaluate opportunities, where legalized by state legislation or related to rescheduling, in the United States. There continues to be a shift in the public’s perception of cannabis from a state of prohibition to a state of legalization across North America. In October 2018, Canada became the first major industrialized nation to legalize adult-use cannabis at the national federal level. Cannabis is still heavily regulated, however, the medical use of cannabis is now permitted in up to 29 countries and many more countries have reformed, or are considering reforming, their cannabis related laws to permit the medical and/or recreational production, distribution, sale and use of cannabis.
Quoted from its 10-K, filed 31 Mar 2026. Read the filing on SEC.gov ↗
Company facts
- Sector
- Health Care
- Industry
- Pharmaceuticals
- Listed since
- 22 Sept 2015
- Employees
- 1
- Website
- targetgroupinc.ca ↗
- Head office
- 20 HEMPSTEAD DRIVE, HAMILTON, L8W 2E7
- Incorporated in
- DE
- Classification
- Medicinal Chemicals & Botanical Products
- Filer status
- Non-accelerated filer<br>Smaller reporting company
Leadership
Pay as last reported
- Mr. Anthony ZarconeChief Executive Officer, Principal Financial Officer, Director, since 2019$104,250
- Mr. Barry KatzmanDirector, since 2019
- Mr. Saul NiddamDirector
Environmental, social and governance
Scores out of 100, from our data supplier
- Overall
- 0
- Environment
- 0
- Social
- 0
- Governance
- 0
SWOT analysis
AI-generated by our data supplier. Not written or checked by our editors.
Strengths
- Target Group Inc has a strong brand reputation and a wide customer base.
- They have a robust supply chain management system, enabling efficient product distribution.
Weaknesses
- Target Group Inc's profit margins have been decreasing due to increased competition.
- The company has faced criticism for certain marketing practices, affecting customer perception.
Opportunities
- The growing trend of e-commerce presents an opportunity for Target Group Inc to expand their online presence.
- Entering new international markets can help Target Group Inc expand their customer base and increase revenue.
Threats
- Increasing labor and raw material costs can impact Target Group Inc's profitability.
- Changes in consumer preferences and shopping habits pose a threat to Target Group Inc's traditional retail model.
Sources and methodology
- Data on this tab
- Our data supplier
- Chart on the Overview
- TradingView
Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.